Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ALKEM LABS LTD

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 48
  • 0 comments

FDA approve TICAGRELOR

Comment Full text

JANSSEN PHARMS

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 39
  • 0 comments

FDA approve PALIPERIDONE PALMITATE

Comment Full text

MYLAN

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 50
  • 0 comments

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

AUROBINDO PHARMA USA

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 46
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

UPSHER SMITH LABS

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 45
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

ENDO OPERATIONS

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 49
  • 0 comments

FDA approve CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE

Comment Full text

PYROS PHARMS

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 41
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

ZHEJIANG POLY PHARM

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 51
  • 0 comments

FDA approve AMIODARONE HYDROCHLORIDE

Comment Full text

PRINSTON INC

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 47
  • 0 comments

FDA approve BUSULFAN

Comment Full text

NOVUGEN

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 43
  • 0 comments

FDA approve LENALIDOMIDE

Comment Full text
  • Previous
  • 356
  • 357
  • 358
  • 359
  • 360
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158469)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin